Dexcom Celebrates the Inauguration of Its New Facility in Penang, Boosting Malaysia’s Medical Technology Ecosystem
PENANG, 12 November 2024 – Dexcom Malaysia Sdn. Bhd. (Dexcom), a renowned global leader in continuous glucose monitoring for people with diabetes, today celebrated the opening of its new state-of-the-art facility at Batu Kawan Industrial Park (BKIP), Penang. The facility will house Dexcom’s Trinity North and South Campus operations on a 28-acre plot, spanning approximately 887,510-square-feet.
The inauguration of the new facility was attended by YAB Tuan Chow Kon Yeow, Chief Minister of Penang, ADUN Bukit Tambun; Dato’ Aziz Bakar, Chief Executive Officer of Penang Development Corporation; Dato’ Loo Lee Lian, Chief Executive Officer of Invest Penang; Ms. Norbaya Kamaludin, Director, MITI, Pulau Pinang; Mr. Faizal Jalaludin, Executive Director, Investment Promotion, MIDA; along with Mr. Jake Leach, Chief Operating Officer; Mr. Barry Regan, Executive Vice President of Global Operations; Mr. Columba McGarvey, Managing Director and Vice President of Operations, Dexcom Malaysia; YB Tuan Goh Choon Aik, and representatives from government agencies, industry partners, Dexcom’s senior leadership, key customers, suppliers and employees.
YAB Tuan Chow Kon Yeow, Chief Minister of Penang stated, “The establishment of this new facility highlights Dexcom’s continued commitment to take control of health through innovative continuous glucose monitoring (CGM) systems. It also reaffirms Penang’s reputation as a global hub for advanced technological industries, reinforcing its position as a preferred destination for high-quality manufacturing and innovation.”
He added, “Leveraging on over 50 years of industry excellence, Penang is on the right path towards becoming the MedTech Hub of Southeast Asia. Housing the largest amount of MedTech companies nationally and regionally, Penang remains a highly attractive location for its infrastructure availability and ecosystem that meet the needs of the MedTech industry.”
Datuk Sikh Shamsul Ibrahim Sikh Abdul Majid, Chief Executive Officer (CEO) of MIDA highlighted the transformative impact of Dexcom’s investment, stating, “Dexcom’s establishment in Malaysia signifies a pivotal moment for our medical devices sector. This state-of-the-art facility will drive advancements in our point-of-care segment, leading to the creation of high-value job opportunities and facilitating technology transfer. This project aligns with the objectives of our New Industrial Master Plan 2030, particularly in fostering economic complexity through innovation and nurturing a skilled talent pool. MIDA is confident that the country’s supply chain resilience will further bolster Dexcom’s growth trajectory in Malaysia by enhancing the local supplier ecosystem.”
“It’s a proud day for all of us here at Dexcom Malaysia as we unveil this new facility, an investment that speaks to our commitment for both our world-class continuous glucose monitoring technology and for Malaysia, and Penang specifically, as a premier location for advanced medical device manufacturing. We’re investing not only in facilities and high-volume automation – but also in people and the power of local talent,” said Mr. Columba McGarvey, Managing Director and Vice President of Operations, Dexcom Malaysia.
“Today’s ribbon cutting represents a meaningful step forward in our journey of innovation and impact,” added Dexcom Chief Operating Officer, Mr. Jake Leach. “Dexcom was founded 25 years ago with the mission to facilitate and improve the health of people with diabetes. Today, we can proudly say that we have done just that and much more, pioneering an entire industry that has transformed how people with diabetes manage their health.”
Dexcom’s new facility will be instrumental in meeting the growing demand for its technology in the Asia-Pacific region. This investment reinforces Dexcom’s commitment to quality, community, and growth in Malaysia.
**The End**
About MIDA
MIDA is the government’s principal investment promotion and development agency under the Ministry of Investment, Trade and Industry (MITI) to oversee and drive investments into the manufacturing and services sectors in Malaysia. Headquartered in Kuala Lumpur Sentral, MIDA has 12 regional and 21 overseas offices. MIDA continues to be the strategic partner to businesses in seizing the opportunities arising from the technology revolution of this era. For more information, please visit www.mida.gov.my and follow us on X, Instagram, Facebook, LinkedIn, TikTok and YouTube.
About InvestPenang
InvestPenang is the Penang State Government’s principal agency for the promotion of investment. Its objectives are to develop and sustain Penang’s economy by enhancing and continuously supporting business activities in the State through foreign and local investments, including spawning viable new growth centers. To realise its objectives, InvestPenang also runs initiatives like the SMART Penang Center (providing assistance to SMEs), Penang CAT Center (for talent attraction and retention), and Global Business Services (GBS) Focus Group (promoting and developing digital economy). For more information, please visit https://investpenang.gov.my/ and follow InvestPenang’s social media channels: Facebook; LinkedIn; WhatsApp Channel; TikTok.
For more information, please contact:
MIDA
Ms. Azlina Binti Hamdan
Director of Life Sciences and Medical Technology Division, MIDA
T: 03-2267 3791
E: [email protected]
InvestPenang
Elaine Cheah / Arief Ferdaus
Communications & Business Intelligence
T: +604-646 8833
E: [email protected] / [email protected]
